Colon cancer blood test offers new screening option
A blood test for colon cancer performed well in a study published Wednesday, offering a new kind of screening for a leading cause of cancer deaths.
The test looks for DNA fragments shed by tumor cells and precancerous growths. It’s already for sale in the U.S. for $895, but has not been approved by the Food and Drug Administration and most insurers do not cover it. The maker of the test, Guardant Health, anticipates an FDA decision this year.
In the study, the test caught 83% of the cancers but very few of the precancerous growths found by colonoscopy, the gold standard for colon cancer screening. Besides spotting tumors, colonoscopies can prevent the disease by removing precancerous growths called polyps.
But some people avoid the exam because of the hassle of getting time off work or the day-ahead preparation that involves drinking a strong laxative to empty the bowels.
Related articles
Iran's nuclear policy unlikely to change even after president's death
DUBAI, United Arab Emirates (AP) — While Iran’s nuclear program stands at the precipice of tipping o2024-05-22Peng Liyuan Visits National Museum of China with Philippine First Lady
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-22Xi Delivers Written Remarks at 15th China
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-22Beijing looks to boost green technology development
Beijing will strive to ramp up the development of green technology in its municipal administrative c2024-05-22Guardians ruin Francisco Lindor's Cleveland homecoming, trip Mets 3
CLEVELAND (AP) — Ben Lively had another solid start, David Fry drove in two early runs and the Cleve2024-05-22Xi Meets Chairman of Presidential Leadership Council of Yemen
Contact Us HomeNewsHighlightACWF NewsSocietyWom2024-05-22
atest comment